Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Wen'an
ENRICH-AF, NCT03950076 / 2019-002075-33: EdoxabaN for IntraCranial Hemorrhage Survivors with Atrial Fibrillation	Active, not recruiting	4	948	Europe, Canada, US, RoW	Edoxaban, Lixiana, Savaysa, Non-anticoagulant medical therapy	Population Health Research Institute	Intracranial Hemorrhages, Atrial Fibrillation	04/26	10/26